Yesterday, Oct. 28, 2015, 36 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $57.69 to $107,598,400.00.

Highlighted Stocks Traded by Insiders:

Actuant (ATU) - FREE Research Report

Roundhouse Roger, who is Exec VP Engd Solutions Segment at Actuant, bought 9,200 shares at $21.74 on Oct. 28, 2015. Following this transaction, the Exec VP Engd Solutions Segment owned 24,278 shares meaning that the stake was boosted by 61.02% with the 9,200-share transaction.

Skogg Eugene Edward, who is EVP-Human Resources at Actuant, bought 8,076 shares at $21.50 on Oct. 28, 2015. Following this transaction, the EVP-Human Resources owned 34,720 shares meaning that the stake was boosted by 30.31% with the 8,076-share transaction.

The shares most recently traded at $22.78, up $1.28, or 5.62% since the insider transaction. Historical insider transactions for Actuant go as follows:

  • 4-Week # shares bought: 7,000
  • 4-Week # shares sold: 5,117
  • 12-Week # shares bought: 7,000
  • 12-Week # shares sold: 5,117
  • 24-Week # shares bought: 7,000
  • 24-Week # shares sold: 5,117

The average volume for Actuant has been 875,900 shares per day over the past 30 days. Actuant has a market cap of $1.3 billion and is part of the industrial goods sector and industrial industry. Shares are down 18.76% year-to-date as of the close of trading on Wednesday.

Actuant Corporation designs, manufactures, and distributes a range of industrial products and systems worldwide. It operates in three segments: Industrial, Energy, and Engineered Solutions. The stock currently has a dividend yield of 0.19%. The company has a P/E ratio of 66.4. Currently, there are 3 analysts who rate Actuant a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ATU - FREE

TheStreet Quant Ratings

rates Actuant as a

hold

. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full

Actuant Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Spectranetics (SPNC) - FREE Research Report

Pelak Daniel A, who is Director at Spectranetics, bought 8,000 shares at $12.45 on Oct. 28, 2015. Following this transaction, the Director owned 71,683 shares meaning that the stake was boosted by 12.56% with the 8,000-share transaction.

The shares most recently traded at $12.19, down $0.26, or 2.13% since the insider transaction. Historical insider transactions for Spectranetics go as follows:

  • 4-Week # shares bought: 8,000
  • 4-Week # shares sold: 5,000
  • 12-Week # shares bought: 18,000
  • 12-Week # shares sold: 5,000
  • 24-Week # shares bought: 51,000
  • 24-Week # shares sold: 5,000

TST Recommends

The average volume for Spectranetics has been 810,100 shares per day over the past 30 days. Spectranetics has a market cap of $508.7 million and is part of the health care sector and health services industry. Shares are down 65.27% year-to-date as of the close of trading on Wednesday.

The Spectranetics Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes single-use medical devices used in minimally invasive procedures in the cardiovascular system. Currently, there are 9 analysts who rate Spectranetics a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SPNC - FREE

TheStreet Quant Ratings

rates Spectranetics as a

sell

. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, feeble growth in its earnings per share, generally high debt management risk and generally disappointing historical performance in the stock itself. Get the full

Spectranetics Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Hawaiian Holdings (HA) - FREE Research Report

Poomaihealani Samson, who is Director at Hawaiian Holdings, sold 16,381 shares at $35.02 on Oct. 28, 2015. Following this transaction, the Director owned 22,921 shares meaning that the stake was reduced by 41.68% with the 16,381-share transaction.

Dunkerley Mark B, who is President and CEO at Hawaiian Holdings, sold 12,000 shares at $35.50 on Oct. 28, 2015. Following this transaction, the President and CEO owned 937,068 shares meaning that the stake was reduced by 1.26% with the 12,000-share transaction.

Falvey Barbara, who is SVP-Human Resources at Hawaiian Holdings, sold 10,000 shares at $35.25 on Oct. 28, 2015. Following this transaction, the SVP-Human Resources owned 74,702 shares meaning that the stake was reduced by 11.81% with the 10,000-share transaction.

The shares most recently traded at $34.86, down $0.39, or 1.12% since the insider transaction. Historical insider transactions for Hawaiian Holdings go as follows:

  • 4-Week # shares sold: 111,568
  • 12-Week # shares sold: 170,395
  • 24-Week # shares bought: 9,209
  • 24-Week # shares sold: 202,395

The average volume for Hawaiian Holdings has been 1.2 million shares per day over the past 30 days. Hawaiian Holdings has a market cap of $1.9 billion and is part of the services sector and transportation industry. Shares are up 34.28% year-to-date as of the close of trading on Wednesday.

Hawaiian Holdings, Inc., through its subsidiary, Hawaiian Airlines, Inc., engages in the scheduled air transportation of passengers and cargo. The company has a P/E ratio of 14.2. Currently, there are 4 analysts who rate Hawaiian Holdings a buy, 2 analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HA - FREE

TheStreet Quant Ratings

rates Hawaiian Holdings as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, good cash flow from operations, expanding profit margins and notable return on equity. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full

Hawaiian Holdings Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.